These clinical data on CCR6 and macrophage infiltration that indicate poor prognoses in RCC patients are consistent with in vitro results and strongly support the important role of infiltrating macrophages and the CCL20-CCR6 axis in RCC progression. This evidence concerns the gene CCR6 and renal cell carcinoma.